This inventor holds 3 USPTO granted patents. Top assignee: Meiji Seika Kabushiki Kaisha. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Emiko Hatsushiba: Innovator in Platelet Aggregation Inhibition
Introduction
Emiko Hatsushiba is a prominent inventor based in Kanagawa-ken, Japan. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit platelet aggregation. With a total of 3 patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
Among her latest patents is a groundbreaking compound with platelet aggregation inhibitor activity. This compound is represented by a general formula and includes pharmaceutically acceptable salts and solvates that effectively inhibit the agglutination of platelets. The specific structure of the compound is detailed as follows: ##STR1##, wherein R.sup.1 represents a group --W--(CH.sub.2).sub.i --COOR.sup.3.
Career Highlights
Emiko Hatsushiba is currently employed at Meiji Seika Kabushiki Kaisha, a leading company in the pharmaceutical industry. Her innovative research and development efforts have positioned her as a key figure in her field.
Collaborations
Throughout her career, Emiko has collaborated with notable colleagues, including Kiyoaki Katano and Shokichi Ohuchi. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Emiko Hatsushiba's work in developing platelet aggregation inhibitors showcases her dedication to advancing medical science. Her contributions are invaluable, and her patents reflect her innovative spirit and commitment to improving healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile